Τrite, booster dose vaccine for COVID-19 eight months after completing their initial vaccination, has decided to recommend to most Americans the government of US President Joe Biden, according to The New York Times.
The American newspaper cites two government officials informed about it.
The Biden government plans to make this recommendation soon, possibly within the next week, according to the NYT report, as broadcast by the Athens News Agency.
Third, boosting doses are possible to be administered around mid-September, according to the post.
ΤThe issue of administering the third, booster dose of the vaccine is a topical issue for developed countries that have vaccinated the largest percentage of their population. The emergence and dominance of the SARS-CoV-2 Delta strain, even in countries with a high level of vaccination coverage, has prompted many countries to start vaccination programs with additional booster doses.
The doctors of the Therapeutic Clinic of the Medical School of the National and Kapodistrian University of Athens, Theodora Psaltopoulou, Giannis Danasis, Panos Malandrakis and Thanos Dimopoulos (Rector of EKPA) summarized a relevant recent publication in the prestigious scientific journal 59 (17, 17) Nature 17
«Administration of a third dose to those already vaccinated may result in a faster and stronger immune response to SARS-CoV-2.
The results of studies that confirm exactly this have started and are being published. Third doses of vaccines developed by Moderna, Pfizer – BioNTech, Oxford – AstraZeneca and Sinovac led to an increase in the levels of “neutralizing” antibodies that fight SARS-CoV-2, when administered several months after the second dose. A current clinical trial in the United Kingdom will test different combinations of booster vaccine doses, including different types of vaccine compared to the original vaccine. “Preliminary studies of the heterologous vaccination approach show that strong immune responses are released, characterized by high levels of antibodies and T lymphocytes, which have strong antiviral activity,” they say, among other things.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
